| 000 | 01861 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518023624.0 | ||
| 264 | 0 | _c20190729 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1178-2005 | ||
| 024 | 7 |
_a10.2147/COPD.S190086 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBloom, Chloe I | |
| 245 | 0 | 0 |
_aChanges in COPD inhaler prescriptions in the United Kingdom, 2000 to 2016. _h[electronic resource] |
| 260 |
_bInternational journal of chronic obstructive pulmonary disease _c |
||
| 300 |
_a279-287 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadministration & dosage |
| 650 | 0 | 4 |
_aAdrenergic beta-2 Receptor Agonists _xadministration & dosage |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBronchodilator Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDatabases, Factual |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aDrug Prescriptions |
| 650 | 0 | 4 | _aElectronic Health Records |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGuideline Adherence _xtrends |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMuscarinic Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aNebulizers and Vaporizers _xtrends |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aPractice Patterns, Physicians' _xtrends |
| 650 | 0 | 4 |
_aPrimary Health Care _xtrends |
| 650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdiagnosis |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUnited Kingdom _xepidemiology |
| 700 | 1 | _aElkin, S L | |
| 700 | 1 | _aQuint, J K | |
| 773 | 0 |
_tInternational journal of chronic obstructive pulmonary disease _gvol. 14 _gp. 279-287 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2147/COPD.S190086 _zAvailable from publisher's website |
| 999 |
_c29382630 _d29382630 |
||